SMTL ID : 7c7g.2 (1 other biounit)

Crystal structures of AKR1C3 ternary complex with NADP+ and the chromene derivative 2j

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.86 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 29 residues within 4Å: Chain A: G.24, T.25, Y.26, D.52, Y.57, H.119, S.168, N.169, Q.192, Y.218, S.219, A.220, L.221, G.222, S.223, Q.224, L.238, A.255, L.270, A.271, K.272, S.273, Y.274, N.275, R.278, Q.281, N.282, F.308 Ligands: FJR.2 25 PLIP interactions: 25 interactions with chain A Hydrophobic interactions: A:F.308 Hydrogen bonds: A:T.25, A:Y.26, A:D.52, A:D.52, A:Y.57, A:S.168, A:N.169, A:Q.192, A:S.219, A:L.221, A:S.223, A:Q.224, A:K.272, A:K.272, A:S.273, A:Y.274, A:R.278, A:N.282, A:N.282 Water bridges: A:A.220, A:Q.224 Salt bridges: A:K.272, A:R.278 pi-Stacking: A:Y.218

1 x FJR: 2-azanylidene-N-(4-methylphenyl)-8-oxidanyl-chromene-3-carboxamide(Non-covalent)

FJR.2: 15 residues within 4Å: Chain A: L.56, Y.57, W.88, S.89, H.119, S.120, M.122, L.124, F.141, N.169, W.229, F.308, F.313, H.316 Ligands: NAP.1 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:L.56, A:Y.57, A:W.88, A:M.122, A:L.124, A:L.124, A:F.141 Hydrogen bonds: A:Y.57 Water bridges: A:S.120 pi-Stacking: A:Y.26, A:W.229, A:F.308, A:F.313

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Endo, S. et al., Development of Novel AKR1C3 Inhibitors as New Potential Treatment for Castration-Resistant Prostate Cancer. J.Med.Chem. (2020)

Release Date

2020-09-23

Peptides

Aldo-keto reductase family 1 member C3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Aldo-keto reductase family 1 member C3

Related Entries With Identical Sequence